This site contains promotional content intended for UK Healthcare Professionals and other relevant decision makers | Not a HCP? Visit our  Public Site.

Adverse Event reporting can be found at the bottom of the page | Prescribing Information for the relevant medicine can be found adjacent to the below content and/or in the footer below. 

Cardiovascular
Cardiovascular
Womens Health
Women's Health
two kidneys
Nephrology
Oncology
Oncology
Ophthalmology
Ophthalmology
Respiratory
Respiratory
Bayer for ProfessionalsYour Resource Portal
Ophthalmology Podcasts

The Macular Minute Episode 11

with Hani Hasan

The Macular Minute Banner

The Importance of Clinical Audits

In this

3-minute
episode, we are joined by
Hani Hasan
, a Consultant Ophthalmologist at Newcastle upon Tyne Hospitals NHS Foundation Trust, to discuss the
importance of clinical audits
.

 

This promotional podcast series has been organised and funded by Bayer and is for UK healthcare professionals only.

Prescribing information for EYLEA® (aflibercept) 8 mg

can be found here
.

Prescribing information for EYLEA® (aflibercept) 2 mg

can be found here
.

Hani Hasan

Consultant Ophthalmologist with special interest in diabetic eye disease, ocular side effects of medications, ocular coherence tomography, and general retina pathology.

Based at the Royal Victoria Infirmary, Newcastle upon Tyne.

 

Speaker Disclosures

Speaker and travel grants: AbbVie, Bayer and Roche

References

  1. EYLEA® 40 mg/mL Summary of Product Characteristics.
  2. EYLEA® 114.3 mg/mL Summary of Product Characteristics.
EYLEA® (aflibercept) 8 mg
Discover data and resources about EYLEA 8 mg
PP-EYL-GB-2911, July 2025
The Macular Minute: Podcast Series
Your source for quick expert insights in medical retina
PP-EYL-GB-2538, January 2025
EYLEA® (aflibercept) 2 mg
Discover data and resources about EYLEA 2 mg
PP-EYL-GB-2793, March 2025

PP-EYL-GB-2551 | December 2024